Simplified Criteria Using Pleural Fluid Cholesterol and Lactate Dehydrogenase to Distinguish between Exudative and Transudative Pleural Effusions

Abstract

Background: An important part of the investigation of pleural effusion is the identification of markers that help separate exudate from transudate. Objectives: The purposes of this study were to compare the accuracy of published and new sets of criteria to distinguish between exudative and transudative pleural effusions, and to determine whether serum biochemical analysis is necessary. Methods: An externally validated cohort study was performed. Pleural effusions were determined to be transudative or exudative on the basis of an assessment of the medical record by two clinicians blinded to biochemical results. Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and area under the receiver operating characteristic curve were determined for each proposed combination of criteria. Results: Pleural fluid analysis was available for 311 thoracenteses in the main cohort and for 112 thoracenteses in the validation cohort. The best sensitivity (97% [95% CI 94–99]) and negative likelihood ratio (0.04 [95% CI 0.02–0.08]) for identifying exudative effusions were observed with criteria combining pleural fluid lactate dehydrogenase greater than 0.6 the upper limit of normal serum lactate dehydrogenase and pleural fluid cholesterol greater than 1.04 mmol/L (40 mg/dL). The overall diagnostic accuracy was similar to Light’s criteria. Findings were similar in the validation cohort. Conclusions: Our proposed criteria using simultaneously pleural fluid lactate dehydrogenase and pleural fluid cholesterol can identify an exudate with a sensitivity and an overall diagnostic accuracy similar to Light’s criteria. It avoids simultaneous blood sampling, thus reducing patient discomfort and potential costs.

Metabolic Changes in SARS-CoV-2 Infection: Clinical Data and Molecular Hypothesis to Explain Alterations of Lipid Profile and Thyroid Function Observed in COVID-19 Patients

“…A final hypothetical mechanism linking the lipid profile and COVID-19 concerns the altered vascular permeability induced by SARS-COV-2 infection, which can lead to the accumulation of exudative fluids in the alveoli [ 5 , 6 ]. As effusion contains proteins and cholesterol [ 18 , 19 , 20 ], the cholesterol exudate accumulating in the alveolar cavities due to the increase in vascular permeability could lead to a reduction in serum cholesterol levels.…”

GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion

“…The study was approved by the Ethics Committee of the Hospital. MPE 21,23 : find malignant cells in PE and/or on closed pleural biopsy specimen. (In our study, all the MPEs are secondary to metastases to the pleura from lung).…”

Pleural fluid biochemistry: A first step toward an etiological diagnosis of pleural effusions

“…On the other hand, the differential leukocyte count is of interest in all pleural exudates because the predominance of a specific cell type, either neutrophils or lymphocytes, can help to narrow down the differential diagnosis. identification of exudates (94% sensitivity and 88% specificity) [21][22][23] .…”